Production process of medicinal oil for treating meridian diseases
A production process and medicated oil technology, applied in the field of medicine, to achieve the effect of strong cell regeneration, good lubricity, and promoting blood circulation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0015] Embodiment 1: A kind of medicated oil production process for the treatment of meridian diseases, the medicated oil comprises the following raw material components in parts by weight: 2 parts of Panax notoginseng, 2 parts of safflower, 3 parts of Sperantospermia, 3 parts of Shenjincao, pepper fine 1 part of pungent, 1 part of longan, 0.5 part of menthol, 1 part of frankincense essential oil, 30 parts of the first aqueous phase, 0.3 part of hydroxyethyl cellulose, 10 parts of glycerin, 5 parts of propylene glycol, 0.02 part of flavoring agent, nonylphenol 0.12 parts of polyether-10, 4 parts of the second aqueous phase, 0.5 parts of nicotinamide, 0.01 parts of polyglutamic acid, 1 part of sweet almond oil, 1 part of lavender essential oil, 1 part of ginger essential oil, 2 parts of German chamomile essential oil, 2 parts jojoba essential oil, 1 part pomegranate seed essential oil, 1 part marjoram essential oil, 1 part patchouli essential oil.
[0016] In this implementatio...
Embodiment 2
[0023] Embodiment 2: A kind of medicated oil production process for the treatment of meridian diseases, the medicated oil comprises the following raw material components in parts by weight: 3 parts of Panax notoginseng, 3 parts of safflower, 4 parts of Speranthema, 4 parts of Shenjincao, pepper fine 1.5 parts of pungent, 1.5 parts of longan, 0.8 parts of menthol, 2 parts of frankincense essential oil, 33 parts of the first aqueous phase, 0.35 parts of hydroxyethyl cellulose, 13 parts of glycerin, 8 parts of propylene glycol, 0.025 parts of flavoring agent, nonylphenol 0.12 parts of polyether-10, 4.5 parts of the second aqueous phase, 0.8 parts of nicotinamide, 0.01 parts of polyglutamic acid, 1.5 parts of sweet almond oil, 1.5 parts of lavender essential oil, 1.5 parts of ginger essential oil, 3 parts of German chamomile essential oil, Jojoba essential oil 3 parts, pomegranate seed essential oil 1.5 parts, marjoram essential oil 1.5 parts, patchouli essential oil 1.5 parts.
...
Embodiment 3
[0031] Embodiment 3: A kind of medicated oil production process for the treatment of meridian diseases, the medicated oil comprises the following raw material components in parts by weight: 4 parts of Panax notoginseng, 4 parts of safflower, 5 parts of Sperancus, 5 parts of Shenjincao, pepper fine 2 parts of pungent, 2 parts of longan, 1 part of menthol, 3 parts of frankincense essential oil, 35 parts of the first aqueous phase, 0.4 parts of hydroxyethyl cellulose, 15 parts of glycerin, 10 parts of propylene glycol, 0.03 parts of flavoring agent, nonylphenol 0.13 parts of polyether-10, 5 parts of the second aqueous phase, 1 part of nicotinamide, 0.02 parts of polyglutamic acid, 2 parts of sweet almond oil, 2 parts of lavender essential oil, 2 parts of ginger essential oil, 4 parts of German chamomile essential oil, 4 parts jojoba essential oil, 2 parts pomegranate seed essential oil, 2 parts marjoram essential oil, 2 parts patchouli essential oil.
[0032] In this implementati...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com